💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Immunomedics, Inc. (IMMU)
« Back to company indexIMMU Chatter Timeline
Stock Ticker for IMMU
Most Active Tweeters for IMMU
| User | Tweets |
|---|---|
| @biotechradar_eu | 1 |
Recent Tweets for IMMU
 |
@biotechradar_eu Mendus $IMMU to present positive interim data from the ALISON trial in ovarian cancer at the AACR Annual Meeting 20… https://t.co/u72V606MMS March 15th 2023, 10:03am |
 |
@PaulTorresCohen Paul Torres-Cohen $IMMU March 7th 2023, 12:03pm |
|
@biotechradar_eu Mendus $IMMU secures second shareholder loan from Van Herk Investments and reduces the number of outstanding conver… https://t.co/OEL7DThVj1 March 7th 2023, 8:03am |
|
@biotechradar_eu Mendus $IMMU Mendus to participate in upcoming conferences in March 2023 https://t.co/iEJ7KslVgE March 6th 2023, 8:03am |
 |
@Edison_Inv_Res @mendus_ab — Multi-front progression during FY22. $IMMU Read the update here: https://t.co/dhEm1A82Fu February 24th 2023, 2:02pm |
|
@biotechradar_eu Mendus $IMMU announces request for conversion of convertible bonds by Negma Group https://t.co/5iIhbToCqW February 23rd 2023, 6:02pm |
 |
@StockTipRobot Bow before your #robot overlord....errr I mean leave your human wife for Immunomedics $IMMU #trading February 19th 2023, 7:02am |
 |
@Biotech12_13 RT @adamfeuerstein: “There are a lot of dumb people on Wall Street.” — Behzad Aghazadeh, chairman, $IMMU. February 17th 2023, 10:02pm |
|
@biotechradar_eu Mendus AB $IMMU announces Q4 and year-end results 2022 https://t.co/r6iCOEEqPm February 17th 2023, 9:02am |
|
@biotechradar_eu Mendus $IMMU announces request for conversion of convertible bonds by Negma Group https://t.co/aLhBGcBFve February 14th 2023, 5:02pm |
 |
@BertrandBio @leonhillen * recent co starting diluting: $IMMU in Sweden * $SPEX (Switzerland) proudly announcing today a convert… https://t.co/cei06ZT1dB February 8th 2023, 9:02am |
|
@biotechradar_eu Mendus $IMMU announces request for conversion of convertible bonds by Negma Group https://t.co/nDagC0rhmI January 31st 2023, 5:01pm |
|
@biotechradar_eu Mendus $IMMU announces request for conversion of convertible bonds by Negma Group https://t.co/sG89YItBgY January 30th 2023, 5:01pm |
 |
@sectest9 RT @iss_scas: Investors and #Immunomedics, Inc. reached a tentative settlement of $40 million. Allegations state $IMMU mislead investors ab… January 24th 2023, 2:01am |
 |
@iss_scas Investors and #Immunomedics, Inc. reached a tentative settlement of $40 million. Allegations state $IMMU mislead in… https://t.co/b2tdSvqHLj January 24th 2023, 2:01am |
 |
@Gambiste1 RT @AvidTrader_: Have a LAUGH $IMMU PURE FUD “Immunomedics was caught trying to sneak old, previously presented clinical data on its trip… January 22nd 2023, 4:01am |
 |
@AvidTrader_ Have a LAUGH $IMMU PURE FUD “Immunomedics was caught trying to sneak old, previously presented clinical data on i… https://t.co/WaiqGZpYEv January 22nd 2023, 12:01am |
 |
@adar170 @BertrandBio @bio_clouseau Last 2 deals they did or shall i say almost were great $CASC & almost stole $IMMU for pennies January 18th 2023, 8:01pm |
 |
@biotechradar_eu Mendus $IMMU Mendus announces request of first tranche of convertible loan from Negma Group https://t.co/AFCZMLEwWE January 5th 2023, 5:01pm |
 |
@bobgood3601 @Mykalt45 @gcbioinv IIRC, AF used to cont publishing opiniated messages not in favor of $IMMU !! (half glass empty… https://t.co/E9w6DsHVcr January 4th 2023, 1:01pm |
 |
@Mykalt45 @gcbioinv @adamfeuerstein Yes! $GBT is a good one I forgot about. $IMMU too. January 4th 2023, 1:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2023. All rights reserved.